Kyoto, Japan

Shin Kaneko

This inventor holds 11 USPTO granted patents and 35 published patent applications and 4 EPO patents. Top assignees: Kyoto University, Takeda Pharmaceutical Company Limited, Kirin Holdings Kabushiki Kaisha. Active years: 2020-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shin Kaneko. Retrieved from https://idiyas.com/inventor/shin-kaneko-1pn2v8hd

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 11 

% Patents Active = 81.8

 

Average Co-Inventor Count = 4.1

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2020-2026

Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: Innovations of Shin Kaneko: Pioneering Immunotherapy

Introduction

Shin Kaneko, an accomplished inventor based in Kyoto, Japan, has made significant advancements in the field of immunotherapy. With a total of 8 patents to his name, Kaneko's work primarily focuses on harnessing the power of T cells and NK cells derived from pluripotent stem cells to enhance cell-based immunotherapy. His innovative mindset and dedication to improving medical treatments have positioned him as a notable figure in the realm of biotechnology.

Latest Patents

One of Kaneko's latest patents details a method for inducing T cells for cell-based immunotherapy. This patent outlines several steps vital for the production of T cells and NK cells, including the production method, the culture medium used for cell growth, and techniques to maintain the undifferentiated state of T cells. Notably, the invention incorporates a growth-accelerating agent for T cells or NK cells, utilizing a calcium/calmodulin-dependent protein kinase II (CaMKII) inhibitor derived from bisbenzylisoquinoline alkaloids. The methods disclosed in this patent aim to enhance the proliferation and maintenance of undifferentiated T cells, promoting more effective therapeutic outcomes.

Career Highlights

Shin Kaneko has contributed to prestigious research institutions, including Kyoto University and the National Cancer Center Japan. Through his work at these institutions, he has played a crucial role in advancing research and development in the field of immunology. His innovative approaches have drawn significant attention, underscoring the importance of cutting-edge research in therapeutic applications.

Collaborations

Throughout his career, Kaneko has collaborated with notable colleagues, including Atsutaka Minagawa and Yasushi Uemura. These partnerships have facilitated the exchange of ideas and techniques, fostering an environment conducive to innovative breakthroughs in immunotherapy.

Conclusion

Shin Kaneko continues to exemplify the spirit of innovation through his dedication to advancing medical science. His contributions to the field of immunotherapy not only highlight his inventive prowess but also reflect the collaborative efforts that drive breakthroughs in biotechnology. As research in this area progresses, Kaneko's pioneering work will undoubtedly inspire future innovations aimed at improving patient outcomes in immunotherapy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…